Epidemiologic links between drug use and HIV epidemics: An international perspective

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue SUPPL. 1, 2010, Pages

  Beyrer, Chris ^a   Wirtz, Andrea L ^a   Baral, Stefan ^a   Peryskina, Alena ^b   Sifakis, Frangiscos ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b AIDS Infoshare   (Russian Federation)

Author keywords

HIV; Injecting drug use; Molecular epidemiology; Narcotics trafficking

Indexed keywords

AFRICA; ASIA; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEROIN DEPENDENCE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW; VIRUS LOAD;

HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MOLECULAR EPIDEMIOLOGY; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 78449281730     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181f9c0c9     Document Type: Review

References (42)

1. UNAIDS. AIDS Epidemic Update, 2009. Geneva, Switzerland: UNAIDS, WHO; November 2009. UNAIDS/09.36E/JC1700E.
2. Rhodes T, Singer M, Bourgois P, et al. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005 61:1026-1044.
3. Beyrer C, Jittiwutikarn J, Teokul W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav. 2003;7:153-161.
4. Beyrer C, Patel Z, Stachowiak JA, et al. Characterization of the emerging HIV Type 1 and HCVepidemics among injecting drug users in Dushanbe, Tajikistan. AIDS Res Hum Retroviruses. 2009;25:853-860.
5. Beyrer C, Razak M, Lisam K, et al. Overland heroin trafficking routes and HIV spread in South and Southeast Asia. AIDS. 2000;14:1-9.
6. Latkin C, Forman V, Knowlton A, et al. Norms, social networks, and HIVrelated risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56:465-476.
7. Mathers B, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733-1745.
8. Rhodes T, Ball A, Stimson G, et al. HIV infection associated with drug injecting in the newly independent states, Eastern Europe: the social and economic context of epidemics. Addiction. 1999;94:1323-1336.
9. Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts-16th International AIDS Conference epidemiology plenary. Clin Infect Dis. 2007;7:981-987.
10. Baral S, Trapence G, Motimedi F, et al. HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS One. 2009;4:e4997.
11. Johnston L, Dahoma M, Holman A, et al. HIV infection and related risk behavior among men who have sex with men in Zanzibar, Tanzania. Paper presented at: XVII International AIDS Conference; August 3-8, 2008; Mexico City, Mexico.
12. Odek-Ogunde M, Lore W, Owiti F. Risky behaviours among injecting drug users in Kenya. Presented at: 14th International Conference on the Reduction of Drug Related Harm; April 8, 2003; Chiang Mai, Thailand.
13. Kwon J, Iversen J, Maher L, et al. The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model based analysis. J Acquir Immune Defic Syndr. 2009;51: 462-469.
14. Le Vu S, Le Strat Y, Pillonel J, et al. Population-based HIV incidence in France, 2003 to 2008. (36LB). Presented at: 17th Conference on Retroviruses and Opportunistic Infections; February 17, 2010; San Francisco, CA.
15. Van Den Berg C, Smit C, Van Brussel G, et al. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users Addiction. 2007;102:1454.
16. Institute of Medicine. Development of Medications for the Treatment of Opiate and Cocaine Addictions; Issues for the Government and Cocaine Addictions; Issues for the Government and Private Sector. Washington, DC: National Academy Press; 1995.
17. Zhang L, Zhu J, Rui B, et al. High HIV risk among Uigur minority ethnic drug users in northwestern China. Trop Med Int Health. 2008;13:814-817.
18. Niccolai LM, Shcherbakova IS, Toussova OV, et al.The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health. 2009;86(Suppl 1):131-143. E-pub June 2009.
19. Bogart L, Kral A, Scott A, et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis. 2005;32:27-34. (Pubitemid 40054158)
20. Jenness S, Neaigus A, Hagan H, et al. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS. 2010;24:175-181.
21. Kivelä P, Krol A, Partanen A, et al. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users. Scand J Public Health. 2009;37:357-363.
22. UNODC.World Drug Report 2009. New York, NY: United Nations; 2009.
23. Beyrer C. Human Immunodeficiency Virus infection rates and heroin trafficking: Fearful symmetries. Bull Narc. 2003;14:400-417.
24. Drug Control Headquarters of the Islamic Republic of Iran. Policies, Achievements, Ongoing Programs and Future Plans. Tehran, Iran: IDCH; 2007.
25. Bobkov A, Kazennova E, Selimova L, et al. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J Med Virol. 2004;74: 19106.
26. Todd C, Abed A, Strathdee S, et al. HIV, HCV, and HBV infections and associated risk behavior in injecting drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13:1327-1331.
27. Sanders-Buell E, Saad M, Abed A, et al. A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35-AD. AIDS Res Hum Retroviruses. 2007;23:834-839.
28. Carr J, Nadai Y, Eyzaguirre L, et al. Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J Acquir Immune Defic Syndr. 2005;39:570.
29. RaiM,NerurkarV,Khoja S, et al. Evidence for a "Founder Effect" amongHIVinfected injection drug users (IDUs) in Pakistan. BMCInfect Dis. 2010;10:7-12.
30. Jahani M, Kheirandish P, Hosseini M, et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS. 2009;23: 538-540.
31. U.S. Department of State. Tajikistan: Country Profile. Available at: http:// www.state.gov/r/pa/ei/bgn/5775.htm. Accessed March 24, 2010.
32. Dahoma M, Johnston L, Holman A, et al. HIV and related risk behavior among men who have sex with men in Zanzibar, Tanzania: results of a behavioral surveillance survey. AIDS Behav. 2009. E-pub ahead of print.
33. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014-1028.
34. Wood E, Kerr T, Marshall B, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
35. Zamani S, Kihara M, Gouya M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006;42:342-346.
36. Amon J. Where Darkness Knows No Limits: Incarceration, Ill-Treatment and Forced Labor as Drug Rehabilitation in China. New York: Human Rights Watch; January 2010.
37. Bobrova N, Rhodes T, Power R, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006;82(Suppl 1):S57-S63.
38. Davis W, Johnson B, Randolph D, et al. Risks for HIV infection among users and sellers of crack, powder cocaine and heroin in central Harlem: implications for interventions. AIDS Care. 2006;18: 158-165.
39. Bluthenthal R, Malik M, Grau L, et al. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004 99:1136-1146.
40. Stuckler D, Basu S, McKee M, et al. Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian Countries. Poc Natl Acad Sci. 2008;105: 13280-13285.
41. National AIDS Center (Armenia and Azerbaijan). IDUs as percent of total registered HIV cases: Eastern Europe and Central Asian Countries, 2007. Paper presented at: 18th International Conferenc on the Reduction of Drug-Related Harm; May 2009; Warsaw, Poland.
42. UNODC. Opium Poppy Cultivation in South-East Asia. Vienna, Austria: UNODC Illicit Crop Monitoring Programme ICMP; December 2009.